NON-PROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye implant aims to halt diabetic vision damage
Disease control Recruiting nowThis large, late-stage study is testing a tiny, slow-dissolving implant placed in the eye to see if it can safely stop or reverse damage from diabetic retinopathy. It will compare the new implant to a mock injection procedure in about 930 adults with moderate to severe non-prolif…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE3 • Sponsor: Ocular Therapeutix, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New eye injection trial aims to halt vision loss from diabetes and clots
Disease control Recruiting nowThis study is testing a new drug called ANXV to see if it is safe and might help people with two serious eye conditions: diabetic retinopathy and retinal vein occlusion. A small group of 12 adults will receive the drug as a slow injection into a vein for five days and be monitore…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Annexin Pharmaceuticals AB • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC